IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Cencora, Inc. sources and distributes pharmaceutical products. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Wholesale Trade
Wholesale
$60.49B
42.0K
Chesterbrook, Pennsylvania
Steven H. Collis
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Modest dividend — capital prioritized for reinvestment.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = COR ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$ITRN Ituran Location & Control Ltd. | 74 | 95 | 97 | 62 | - | - | 30.4% | 17.5% | 47.8% | 21.2% | 16.8% | 5.1% | 5.1% | 0.0x | $612M | VS | |
$COR Cencora, Inc. | 70 | 84 | 77 | 70 | 28.5x | 23.2x | 117.7% | 3.1% | 3.6% | 1.1% | 0.8% | 15.8% | 0.7% | 378.0x | $60.5B | ||
$CENT CENTRAL GARDEN & PET CO | 70 | 84 | 95 | 48 | 5.9x | 3.5x | 10.4% | 4.6% | 31.9% | 8.0% | 5.2% | -2.2% | 0.0% | 75.0x | $2.1B | VS | |
$SNX TD SYNNEX CORP | 67 | 80 | 93 | 57 | 13.5x | 6.2x | 10.0% | 2.6% | 7.0% | 2.3% | 1.3% | 6.9% | 1.2% | 55.0x | $12.4B | VS | |
$HLF HERBALIFE LTD. | 65 | 60 | 75 | 96 | 5.0x | 1.4x | -32.4% | 6.3% | 77.7% | 9.9% | 3.4% | 2.7% | 0.0% | - | $870M | VS | |
$GIC GLOBAL INDUSTRIAL Co | 65 | 82 | 60 | 62 | 18.7x | 12.5x | 24.0% | 12.5% | 35.6% | 7.4% | 5.3% | 3.3% | 2.8% | 0.0x | $1.4B | VS | |
$JXG JX Luxventure Group Inc. | 63 | 84 | 75 | 88 | - | - | 20.4% | 11.9% | 16.8% | 7.8% | 6.2% | 56.5% | 0.0% | 22.0x | $6M | VS | |
$FERG Ferguson Enterprises Inc. /DE/ | 63 | 74 | 48 | 67 | 21.4x | 14.3x | 39.4% | 12.6% | 30.7% | 9.4% | 7.0% | 5.1% | 1.3% | 68.0x | $48.9B | VS | |
$SYY SYSCO CORP | 60 | 68 | 49 | 65 | 22.7x | 9.2x | 89.9% | 5.9% | 18.3% | 3.3% | 1.9% | 3.0% | 2.9% | 595.0x | $35.3B | VS | |
$DXPE DXP ENTERPRISES INC | 60 | 58 | 55 | 79 | 21.6x | 8.5x | 25.1% | 6.2% | 31.4% | 8.5% | 4.2% | 8.6% | 0.0% | 128.0x | $1.9B | VS | |
$USFD US Foods Holding Corp. | 59 | 57 | 45 | 76 | 28.2x | 10.8x | 16.5% | 4.3% | 17.2% | 2.8% | 1.5% | 4.8% | 0.0% | 111.0x | $17.2B | VS | |
| SECTOR BENCH | - | - | - | - | - | 19.1x | 8.2x | 8.6% | 2.7% | 22.5% | 3.3% | 1.4% | 3.3% | 0.3% | 0.5x | - | REF |
Cencora, Inc. (COR) receives a "Buy" rating with a composite score of 69.8/100. It ranks #99 out of 7,333 stocks in our coverage universe and carries a 4-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Steven H. Collis
Chief Executive Officer
Labor Force
42,000
84
44
88
Audit Verdict: High quality, disciplined capital allocation, and low volatility suggest strong governance.
No recent insider transactions available for COR
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Top-rated overall — multiple factors aligned for strong entry
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Wholesale Trade sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for COR.
View All RatingsYOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Material decline in asset turnover efficiency detected
Capital Income Projection
A $10,000 capital deployment would generate approximately $71 annually in verified dividends.
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 84 | 99 | -15DRAG |
| MOMENTUM | 70 | 83 | -13DRAG |
| VALUATION | 77 | 91 | -14DRAG |
| INVESTMENT | 44 | 82 | -38DRAG |
| STABILITY | 88 | 97 | -9DRAG |
| SHORT INT | 60 | 72 | -12DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 117.7% (sector 8.6%)
GM 4% vs sector 22%, OM 1% vs sector 3%
Capital turnover N/A
Rev growth 16%, 11yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Cencora, Inc. receives a Buy rating with a composite score of 69.8/100 and 4 out of 5 stars, ranking #99 of 7,333 stocks in our universe. COR displays a favorable combination of factors that positions it above the majority of the market. While not without risk, the quantitative profile supports a constructive outlook.
COR earns a quality score of 84/100, indicating above-average business quality. The company reports a return on equity of 117.7% (sector avg: 8.6%), gross margins of 3.6% (sector avg: 22.5%), net margins of 0.8% (sector avg: 1.4%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
COR carries a solid value score of 77/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 28.47x, an EV/EBITDA of 23.19x, a P/B ratio of 33.51x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
With an investment score of 44/100, COR exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 15.8% vs. a sector average of 3.3% and a return on assets of 3.1% (sector: 2.7%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
COR shows strong momentum characteristics with a score of 70/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at 15.8% year-over-year, while a beta of -0.01 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
Cencora, Inc. earns an excellent stability score of 88/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of -0.01 and a debt-to-equity ratio of 378.00x (sector avg: 0.5x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
COR carries a short interest score of 60/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 378.00x). At $60.5B market cap (large-cap), Cencora, Inc. offers reasonable institutional liquidity.
COR offers a modest dividend yield of 0.7%. This compares to a sector average dividend yield of 0.3%. While the income contribution is relatively small, even a small dividend signals management's commitment to shareholder returns and can serve as a signal of financial discipline.
Cencora, Inc. is a large-cap company in the Wholesale Trade sector, ranked #2 of 50 in its sector (96th percentile) and #99 of 7,333 overall (99th percentile). Key comparisons include ROE of 117.7% exceeding the 8.6% sector median and operating margins of 1.1% below the 3.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Wholesale Trade peers.
Quant Factor Profile
Key factor gap
Stability (88) vs Investment (44) — closing this gap could shift the rating.
RANK #2 OF 50 IN CONSUMER STAPLES
EV/EBITDA 183% ABOVE SECTOR MEDIAN
ROE 1273% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 84% BELOW SECTOR MEDIAN
AUDIT DATA AS OF DEC 31, 2025 (Q3 FY2025)
We rate Cencora, Inc. (COR) as a Buy with a composite score of 69.8/100 at a current price of $364.86. The stock scores above average across the majority of our six quantitative factors and ranks #99 out of 7,333 stocks in our universe, reflecting a favorable risk-reward profile.
The rating is primarily driven by strength in stability (88th percentile) and quality (84th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (44/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Cencora, Inc. holds a top-quartile position (#2 of 50) within the Wholesale Trade sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 69.8/100 places it at rank #99 in our full 7,333-stock universe. With a $60.5B market capitalization, Cencora, Inc. operates at meaningful scale within the Wholesale Trade sector, providing competitive advantages in distribution, procurement, and customer reach.
The near-term outlook is constructive, with revenue growing at 16% and momentum in the 70th percentile confirming positive market sentiment and institutional accumulation. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy. Investment factor at the 44th percentile indicates reinvestment patterns that investors should monitor for sustainability.
The margin cascade tells an important story: gross margins of 4% (-18.9pp vs sector) narrow to operating margins of 1% (-2.2pp vs sector) and net margins of 0.8%, yielding a gross-to-net conversion rate of 21%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $364.86, Cencora, Inc. appears undervalued relative to its fundamentals. Our value factor score of 77/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 28.5x (a 49% premium to the sector median of 19.1x), EV/EBITDA of 23.2x (at a premium), P/B of 33.5x, P/S of 0.2x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis partially supports given strong quality metrics.
The stock's Buy rating (composite score 69.8/100) reflects broad-based quantitative strength, placing it in the top 20% of our 7,333-stock universe.
Returns on equity of 117.7% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
Revenue growth of 16% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A value factor score of 77/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Positive momentum (70th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
We assign a Medium uncertainty rating to Cencora, Inc.. The stock presents a balanced risk profile: significant leverage (378% debt-to-equity) and low beta of -0.01 — while defensive, this may indicate limited upside participation in bull markets. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: significant leverage (378% debt-to-equity); low beta of -0.01 — while defensive, this may indicate limited upside participation in bull markets; the combination of leverage (378% D/E) and thin margins (0.8% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 88th percentile and quality factor at the 84th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: above-average stability (88th percentile) suggests predictable business dynamics; large-cap scale ($60.5B) provides resilience. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate Cencora, Inc.'s capital allocation as Poor. Key concerns include elevated leverage (378% D/E). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Cencora, Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Cencora, Inc. receives a Buy rating with a composite score of 69.8/100 (rank #99 of 7,333). Our quantitative framework assigns a Narrow Moat (44/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 73/100.
Our analysis supports a constructive view on Cencora, Inc.. The combination of identifiable competitive advantages, medium uncertainty, and poor capital allocation creates a risk-reward profile that favors accumulation at current levels. We recommend investors consider adding this name to portfolios aligned with the stock's risk profile.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign Cencora, Inc. a Narrow Moat rating with a composite moat score of 44/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that Cencora, Inc. can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being growth durability at 16.7/20.
The strongest moat sources are growth durability (16.7/20) and economic value creation (15/20). Rev growth 16%, 11yr history. ROE proxy 117.7% (sector 8.6%). These pillars form the core of Cencora, Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and financial resilience (3.1/20). Capital turnover N/A. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Cencora, Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include robust top-line growth of 16% expanding the revenue base, returns on equity of 117.7% driving shareholder value creation. The margin cascade from 4% gross to 1% operating to 0.8% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 84th percentile.
The margin profile shows gross margins of 4%, operating margins of 1%, net margins of 0.8%. Return metrics include ROE of 117.7% and ROA of 3.1%. Relative to the Wholesale Trade sector, gross margins are 18.9 percentage points below the sector median of 22%, and ROE of 117.7% compares to a sector median of 8.6%.
The balance sheet reflects high leverage with D/E of 378%, which may limit financial flexibility, a dividend yield of 0.71%, revenue growth of 16%. The sector median D/E is 1%, putting Cencora, Inc. at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Elevated leverage (378% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of 0.8% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Above 50MA
37.18%
Net New Highs
+51081
Transport and Federal Approvals Now in Hand; UL Safety Certifications on Track to Finalize Q1 2026 WEST SENECA, NEW YORK / ACCESS Newswire / February 19, 2026 / West Seneca, New York, February 19, 2026 - Worksport Ltd. (NASDAQ:WKSP) ("Worksport" or ...
Cencora is set to merge MWI Animal Health with Covetrus in a $3.5B deal, retaining a 34.3% stake as it unlocks capital and targets animal health growth.
Feb 18 (Reuters) - Drug distributor Cencora will merge its MWI Animal Health with privately held Covetrus in a deal valuing the unit at $3.5 billion, the companies said on Wednesday, creating a
Cencora (NYSE:COR) and Covetrus, a global animal health technology and services company, today announced that they have entered into a definitive agreement under which Covetrus and MWI Animal Health (MWI) will merge,
Cencora agreed to acquire a majority stake in OneOncology for $5 billion, funded through new debt financing. The transaction is expected to close by the end of fiscal 2026 second quarter and is anticipated to be earnings neutral in the first twelve months.